These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Whole-body MRI for the staging and follow-up of patients with metastasis. Schmidt GP; Reiser MF; Baur-Melnyk A Eur J Radiol; 2009 Jun; 70(3):393-400. PubMed ID: 19457631 [TBL] [Abstract][Full Text] [Related]
23. A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role? Filonzi G; Mancuso K; Zamagni E; Nanni C; Spinnato P; Cavo M; Fanti S; Salizzoni E; Bazzocchi A AJR Am J Roentgenol; 2017 Jul; 209(1):152-158. PubMed ID: 28418695 [TBL] [Abstract][Full Text] [Related]
24. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656 [TBL] [Abstract][Full Text] [Related]
25. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma. Tateishi U; Hosono A; Makimoto A; Nakamoto Y; Kaneta T; Fukuda H; Murakami K; Terauchi T; Suga T; Inoue T; Kim EE Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939 [TBL] [Abstract][Full Text] [Related]
26. Whole-body MRI of multiple myeloma: comparison of different MRI sequences in assessment of different growth patterns. Weininger M; Lauterbach B; Knop S; Pabst T; Kenn W; Hahn D; Beissert M Eur J Radiol; 2009 Feb; 69(2):339-45. PubMed ID: 18096344 [TBL] [Abstract][Full Text] [Related]
29. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy. Scudla V; Zemanova M; Minarik J; Bacovsky J; Ordeltova M; Indrak K; Budikova M; Dusek L; Farbiakova V Neoplasma; 2006; 53(4):277-84. PubMed ID: 16830053 [TBL] [Abstract][Full Text] [Related]
31. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography. Pfau PR; Perlman SB; Stanko P; Frick TJ; Gopal DV; Said A; Zhang Z; Weigel T Gastrointest Endosc; 2007 Mar; 65(3):377-84. PubMed ID: 17321235 [TBL] [Abstract][Full Text] [Related]
32. Anatomic and functional imaging in the management of lymphoma. Al-Nahhas A; Win Z; Al-Sayed Y; Khan S; Singh A; Rubello D; Gishen P Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):251-9. PubMed ID: 17538524 [TBL] [Abstract][Full Text] [Related]
33. [Whole Body Magnetic Resonance and CT/PET in patients affected by multiple myeloma during staging before treatment]. Falcone C; Cipullo S; Sannino P; Restuccia A Recenti Prog Med; 2012 Nov; 103(11):444-9. PubMed ID: 23096729 [TBL] [Abstract][Full Text] [Related]
34. Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation. Rajkumar SV; Buadi F Best Pract Res Clin Haematol; 2007 Dec; 20(4):665-80. PubMed ID: 18070712 [TBL] [Abstract][Full Text] [Related]
35. Whole-body PET/CT-colonography: a possible new concept for colorectal cancer staging. Kinner S; Antoch G; Bockisch A; Veit-Haibach P Abdom Imaging; 2007; 32(5):606-12. PubMed ID: 17387540 [TBL] [Abstract][Full Text] [Related]
36. Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma. Patnana M; Bronstein Y; Szklaruk J; Bedi DG; Hwu WJ; Gershenwald JE; Prieto VG; Ng CS Clin Radiol; 2011 Mar; 66(3):224-36. PubMed ID: 21295201 [TBL] [Abstract][Full Text] [Related]
37. State of the art imaging of multiple myeloma: comparative review of FDG PET/CT imaging in various clinical settings. Mesguich C; Fardanesh R; Tanenbaum L; Chari A; Jagannath S; Kostakoglu L Eur J Radiol; 2014 Dec; 83(12):2203-2223. PubMed ID: 25308249 [TBL] [Abstract][Full Text] [Related]
38. Fluorodeoxyglucose positron emission tomography in multiple myeloma, solitary plasmocytoma and monoclonal gammapathy of unknown significance. Adam Z; Bolcak K; Stanicek J; Buchler T; Pour L; Krejci M; Prasek J; Neubauer J; Vorlicek J; Hajek R Neoplasma; 2007; 54(6):536-40. PubMed ID: 17949238 [TBL] [Abstract][Full Text] [Related]
39. Early detection of cancer recurrence: 18F-FDG PET/CT can make a difference in diagnosis and patient care. Israel O; Kuten A J Nucl Med; 2007 Jan; 48 Suppl 1():28S-35S. PubMed ID: 17204718 [TBL] [Abstract][Full Text] [Related]
40. Staging monoclonal plasma cell disease: comparison of the Durie-Salmon and the Durie-Salmon PLUS staging systems. Fechtner K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA Radiology; 2010 Oct; 257(1):195-204. PubMed ID: 20851941 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]